GSK/Teva Lamictal settlement
Executive Summary
GlaxoSmithKline and Teva reach agreement in principle to settle patent litigation over anti-epileptic Lamictal. Teva filed lamotrigine ANDA in 2002; pediatric exclusivity expires January 2009 (1"The Pink Sheet" Oct. 28, 2002, p. 11)...